Johnson & Johnson
NYSE: JNJ
$154.58
-$0.35 (-0.2%)
Closing Price on April 25, 2025
JNJ Stock Chart and Intraday Price
JNJ Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 390,509.79M USD |
| Shares Outstanding | 2,408,770,000 |
JNJ Articles
If you are someone who thinks investments should generate regular income, it is important to watch out for dividend stocks. While there are hundreds of dividend-paying companies, you need to look...
Published:
These five Dividend Aristocrats have the least negligible impact from the tariffs and are ideal for passive income investors.
Published:
Most people understand it requires patience for an investment to pay off. The saying, “it’s time in the market, not timing the market” underscores that over the long haul, investing in stocks...
Published:
Markets are moving higher for the second straight day. All thanks to talk of cooling trade war tensions, and President Trump’s admission that he has no plans to fire Federal Reserve Chief Jerome...
Published:
Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from tariff-related volatility.
Published:
The good news for investors seeking high-yield dividend stocks to buy right now is that there are a number of top options for investors to consider in the high-yield dividend world. Outside of much...
Published:
These four perfect safe-haven stocks for worried investors from the S&P Dividend Monarch index offer lower volatility and defensive characteristics that help during market sell-offs.
Published:
If you want a way to combine steady income, stability, and diversification, an exchange-traded fund (ETF) can deliver all three. The iShares Core High ETF (NYSEARCA:HDV) is worth looking into since...
Published:
Four of Wall Street's most beloved blue-chip dividend stocks are on sale. They can provide a steady stream of passive income and a promising avenue for total return.
Published:
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Published:
One of the most controversial policies proposed by President Trump has been his innovative deployment of tariffs. He has already used tariffs as a negotiation tool to motivate Canada and Mexico. He...
Published:
In this age of AI and Magnificent 7 tech stock price volatility, Dividend King stocks still stand apart in the eyes of many income based and institutional investors. Their long, reliable track...
Published:
One tactic for growth and income investors is to consider some of the highest-yielding Dividend Kings. These five make sense for investors seeking passive income streams.
Published:
There are plenty of dividend payers out there, but only some of them qualify as dividend aristocrats, which can loosely be defined as businesses with exemplary track records of paying dividends. Even...
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Market volatility can be unsettling for any investor....
Published:
